Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

FUNDERHOLME SMEDIE ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.9% 1.9%   Bankruptcy risk   1.2% 2.1% 5.7% 1.5% 1.8% 3.6% 9.4% 9.2%   Credit score (0-100)   84 69 40 74 71 52 26 27   Credit rating   A A BBB A A BBB BB BB   Credit limit (kDKK)   150.7 0.5 0.0 14.8 3.3 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   8,223 10,403 7,041 9,698 9,303 7,439 0.0 0.0   EBITDA   1,178 394 -1,799 1,635 1,153 -395 0.0 0.0   EBIT   993 202 -2,110 1,253 778 -782 0.0 0.0   Pre-tax profit (PTP)   826.2 23.2 -2,272.3 1,082.4 545.9 -1,003.2 0.0 0.0   Net earnings   636.1 15.7 -1,774.1 843.6 428.9 -888.3 0.0 0.0   Pre-tax profit without non-rec. items   826 23.2 -2,272 1,082 546 -1,003 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   930 917 2,305 1,959 1,691 1,399 0.0 0.0   Shareholders equity total   3,798 3,514 1,740 2,584 3,012 2,124 1,524 1,524   Interest-bearing liabilities   2,522 3,853 327 3,581 4,045 2,069 0.0 0.0   Balance sheet total (assets)   9,659 10,030 7,211 9,528 10,557 6,501 1,524 1,524   Net Debt   2,494 3,833 320 3,547 4,031 2,054 -1,524 -1,524     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   8,223 10,403 7,041 9,698 9,303 7,439 0.0 0.0   Gross profit growth   -0.4% 26.5% -32.3% 37.7% -4.1% -20.0% -100.0% 0.0%   Employees   19 25 24 19 19 17 0 0   Employee growth %   -9.5% 31.6% -4.0% -20.8% 0.0% -10.5% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   9,659 10,030 7,211 9,528 10,557 6,501 1,524 1,524   Balance sheet change%   38.6% 3.8% -28.1% 32.1% 10.8% -38.4% -76.6% 0.0%   Added value   1,177.9 394.1 -1,798.5 1,635.0 1,160.0 -395.0 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -194 -205 1,077 -728 -643 -679 -1,399 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 3.0 -1.0 1.0 2.0 -1.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   12.1% 1.9% -30.0% 12.9% 8.4% -10.5% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   12.2% 2.1% -24.4% 15.1% 7.8% -9.1% 0.0% 0.0%   ROI %   17.9% 2.9% -39.4% 25.1% 10.7% -12.5% 0.0% 0.0%   ROE %   17.5% 0.4% -67.5% 39.0% 15.3% -34.6% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   39.3% 35.0% 24.1% 27.1% 28.5% 32.7% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   211.7% 972.6% -17.8% 217.0% 349.8% -520.1% 0.0% 0.0%   Gearing %   66.4% 109.7% 18.8% 138.6% 134.3% 97.4% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   10.2% 5.8% 8.1% 9.3% 6.4% 7.6% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   1.4 1.3 0.9 1.1 1.1 1.1 0.0 0.0   Current Ratio   1.6 1.4 1.1 1.2 1.3 1.3 0.0 0.0   Cash and cash equivalent   28.8 20.0 7.3 33.5 13.5 14.5 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   3,084.9 2,804.0 445.4 1,440.4 2,026.2 1,142.4 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   62 16 -75 86 61 -23 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   62 16 -75 86 61 -23 0 0   EBIT / employee   52 8 -88 66 41 -46 0 0   Net earnings / employee   33 1 -74 44 23 -52 0 0